bd biosciences in the United States which state

The United States BD (Becton, Dickinson and Company) was founded in New York in 1897, headquartered in Franklin Lakes, New Jersey, the United States, in about 50 countries and regions around the world with branches of the office, research and development centers and manufacturing plants, business throughout the world's six continents, more than 25,000 employees around the world. The company serves medical institutions, life sciences research institutes, clinical laboratories, industrial units and the general public, and is one of the world's largest medical technology companies producing and marketing medical devices, medical systems and reagents dedicated to improving human health around the world.

BD is focused on improving drug therapy, increasing the quality and speed of diagnosis of infectious diseases, and advancing the research and discovery of novel medicines and vaccines.

BD has a strong research and development capability to fight many of the world's most intractable diseases.

BD is focused on achieving growth in three global business units:

BD Medical is the world's premier supplier of medical devices. Since establishing the first factory for manufacturing needles and syringes in the U.S. in 1906, the company has become a leading innovator of injection and infusion systems.

BD Diagnostics is a leader in products for the safe collection and transport of specimens, as well as products and systems for rapid and accurate analytical testing for infectious diseases, healthcare-associated infections, and cancer detection.

BD Biosciences is a global leader in providing innovative research and clinical diagnostic tools to life science and clinical researchers, laboratory professionals and clinicians. Our customers range from those engaged in basic research, drug and vaccine development, manufacturing biopharmaceuticals, clinical trials, diagnostic testing and disease management.

BD has now become a multinational company operating more than 10,000 products, the world's largest supplier of syringes and medical disposable products, BD syringe products market share is 45% of the global total, accounting for 80% of the total in Europe and the United States. All of the company's products on the market follow the highest standards in the industry and have passed the ISO international quality certification. 2005 global sales reached 5.4 billion U.S. dollars, with nearly 300 million U.S. dollars invested in research and development costs. The company's scale of operations, market share and overall competitiveness have grown by leaps and bounds, and have attracted the attention of peers around the world.

BD, a leader in quality and innovation for over 100 years, will continue to expand its presence in Asia and China, and work with Chinese governments and healthcare organizations to bring the latest medical technology to China to serve the public.

I hope this helps.